Celldex Therapeutics Inc. – Filings and Transcripts

NASDAQ: CLDX
Share price (5/5/26): $33.86
Market cap (5/5/26): $2.658 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Vanguard Capital Management LLC

Vanguard Group Inc

Point72 Asset Management, L.P.

Wellington Management Group Llp

State Street Corporation

News Filter

Announces Proposed Public Offering of Common Stock

Reports Fourth Quarter and Year End 2025 Financial Results and Provides Corporate Update

Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Reports Results From Phase 2 Study of Barzolvolimab in Eosinophilic Esophagitis

Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Proxies Filter

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness